5
Apr
2021
The Glory of John Martin: an Understated Leader Who Built a Biotech Powerhouse
John C. Martin was an unassuming man with an ordinary name. But his leadership qualities and accomplishments as a biopharma CEO were extraordinary. Martin, the CEO of Foster City, Calif.-based Gilead Sciences from 1996 to 2016, didn’t seek to dominate the room or inspire legions with a charismatic personality. He didn’t make the cover of magazines, even when he led... Read More
5
Apr
2021
Compassionate Use Policy Has Everything We Need…Except Policy and Compassion
Biogen is in a bind. The way it navigates a tricky compassionate use situation today could reverberate across the industry for years to come. Full disclosure before diving in — I used to work at Biogen, but left there five years ago. I hold the company in high regard, and am hopeful the company will find a way to solve... Read More
5
Apr
2021
COVID-19 Testing: Going to the Dogs?
For at least the 15,000 years since the first-known burial of two humans with their dog, dogs and humans have cooperated intimately. Dogs get food and shelter in exchange for performing work they can do uniquely well. Working dogs use capabilities, such as strength, speed, alertness and willingness to please (trainability). From the very beginning, it is likely that it... Read More